3% SODIUM CHLORIDE

3% SODIUM CHLORIDE was reported 114 times

3% SODIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRODUCT PROCESS CONTROL ISSUE 1 0.0833
1 TRANSURETHRAL RESECTION SYNDROME 1 0.0400
2 IATROGENIC INFECTION 1 0.0122
3 PRODUCT STERILITY LACKING 1 0.0119
4 CSF CULTURE POSITIVE 1 0.0094
5 PROPIONIBACTERIUM INFECTION 1 0.0093
6 DIALYSIS RELATED COMPLICATION 3 0.0085
7 HAEMODIALYSIS COMPLICATION 1 0.0059
8 EXPOSURE VIA INHALATION 1 0.0046
9 SKULL FRACTURED BASE 1 0.0040
10 ANTITHROMBIN III DECREASED 1 0.0037
11 HYPOPROTHROMBINAEMIA 1 0.0033
12 PRODUCT RECONSTITUTION ISSUE 1 0.0032
13 RETROPERITONEAL ABSCESS 1 0.0032
14 TYMPANIC MEMBRANE DISORDER 1 0.0031
15 OSMOTIC DEMYELINATION SYNDROME 2 0.0027
16 PRODUCT BARCODE ISSUE 1 0.0026
17 PULSE PRESSURE DECREASED 1 0.0020
18 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
19 LEFT ATRIAL DILATATION 2 0.0016
20 PERITONEAL DISORDER 1 0.0015
21 PRODUCT LOT NUMBER ISSUE 3 0.0014
22 PSEUDOMONAS TEST POSITIVE 1 0.0012
23 CARDIAC STRESS TEST ABNORMAL 1 0.0012
24 COLONIC ABSCESS 1 0.0012
25 ULNA FRACTURE 1 0.0010
26 SYSTOLIC DYSFUNCTION 1 0.0009
27 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
28 BRONCHIAL SECRETION RETENTION 1 0.0008
29 PRODUCT EXPIRATION DATE ISSUE 1 0.0007
30 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
31 PRODUCT MONITORING ERROR 1 0.0007
32 GASTROINTESTINAL WALL THICKENING 1 0.0007
33 HAEMORRHAGIC TRANSFORMATION STROKE 1 0.0007
34 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
35 TRANSCRIPTION MEDICATION ERROR 1 0.0006
36 HYPERNATRAEMIA 3 0.0006
37 MALIGNANT PLEURAL EFFUSION 1 0.0006
38 GLIOBLASTOMA 1 0.0006
39 PUPIL FIXED 1 0.0006
40 PRODUCT CONTAINER SEAL ISSUE 1 0.0006
41 PNEUMOPERITONEUM 1 0.0005
42 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
43 RADIUS FRACTURE 1 0.0004
44 RENAL CELL CARCINOMA 2 0.0004
45 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
46 HAEMODIALYSIS 3 0.0004
47 ACUTE PULMONARY OEDEMA 2 0.0004
48 HYPERVENTILATION 2 0.0003
49 ABORTION 1 0.0003
50 MYELOFIBROSIS 1 0.0003
51 OLIGURIA 2 0.0003
52 ABDOMINAL ADHESIONS 1 0.0003
53 BACTERIAL SEPSIS 1 0.0003
54 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
55 SUDDEN CARDIAC DEATH 1 0.0003
56 PRODUCT CONTAMINATION 1 0.0003
57 VENTRICULAR ARRHYTHMIA 1 0.0003
58 UNRESPONSIVE TO STIMULI 7 0.0003
59 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
60 HAEMOLYSIS 2 0.0003
61 APNOEA 2 0.0003
62 CARDIOPULMONARY FAILURE 1 0.0003
63 CEREBRAL ATROPHY 1 0.0003
64 CYSTITIS HAEMORRHAGIC 1 0.0002
65 GASTROINTESTINAL PERFORATION 1 0.0002
66 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
67 OCULAR ICTERUS 1 0.0002
68 WRONG DRUG ADMINISTERED 2 0.0002
69 ILEUS PARALYTIC 1 0.0002
70 INTERCEPTED MEDICATION ERROR 1 0.0002
71 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
72 PULSE ABSENT 1 0.0002
73 HYPERAMMONAEMIA 1 0.0002
74 KLEBSIELLA INFECTION 1 0.0002
75 BLOOD LACTIC ACID INCREASED 1 0.0002
76 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
77 STREPTOCOCCAL INFECTION 1 0.0002
78 INTRACRANIAL PRESSURE INCREASED 1 0.0002
79 STATUS EPILEPTICUS 2 0.0002
80 PRODUCT LABEL CONFUSION 1 0.0002
81 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
82 BRAIN OEDEMA 2 0.0002
83 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
84 INCOHERENT 1 0.0002
85 POOR QUALITY DRUG ADMINISTERED 1 0.0002
86 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
87 MENINGITIS 1 0.0001
88 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
89 WRONG PRODUCT ADMINISTERED 1 0.0001
90 CARDIO-RESPIRATORY ARREST 6 0.0001
91 EXTRASYSTOLES 1 0.0001
92 SUBDURAL HAEMATOMA 2 0.0001
93 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
94 MEDICAL DEVICE COMPLICATION 1 0.0001
95 DRUG DISPENSING ERROR 2 0.0001
96 LIPASE INCREASED 1 0.0001
97 DEVICE RELATED INFECTION 2 0.0001
98 NASAL DISCOMFORT 1 0.0001
99 BLOOD ALBUMIN DECREASED 1 0.0001
100 CARDIOVASCULAR DISORDER 3 0.0001
101 PRODUCT CONTAINER ISSUE 1 0.0001
102 CARDIAC OPERATION 1 0.0001
103 HAEMOLYTIC ANAEMIA 1 0.0001
104 NEPHROPATHY 1 0.0001
105 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
106 SINUS BRADYCARDIA 1 0.0001
107 BONE MARROW FAILURE 2 0.0001
108 TEMPERATURE INTOLERANCE 1 0.0001
109 PRODUCT ODOUR ABNORMAL 1 0.0001
110 TRANSFUSION 1 0.0001
111 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
112 PRODUCT DISPENSING ERROR 2 0.0001
113 TOOTH FRACTURE 1 0.0001
114 FISTULA 1 0.0001
115 MITRAL VALVE INCOMPETENCE 1 0.0001
116 MYOCARDIAL ISCHAEMIA 1 0.0001
117 INJECTION SITE EXTRAVASATION 1 0.0001
118 GENERALISED OEDEMA 1 0.0001
119 INFUSION SITE PAIN 1 0.0001
120 INJECTION SITE INDURATION 1 0.0001
121 MENTAL STATUS CHANGES 2 0.0001
122 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
123 SKIN REACTION 1 0.0001
124 CARDIOGENIC SHOCK 1 0.0001
125 GASTROENTERITIS 1 0.0001
126 ACUTE MYOCARDIAL INFARCTION 2 0.0001
127 CARDIOMYOPATHY 1 0.0001
128 URINARY INCONTINENCE 2 0.0001
129 BLOOD POTASSIUM DECREASED 2 0.0001
130 PHARYNGEAL OEDEMA 1 0.0001
131 METASTASES TO BONE 1 0.0001
132 VENTRICULAR TACHYCARDIA 1 0.0001
133 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
134 INFUSION RELATED REACTION 4 0.0001
135 CIRCULATORY COLLAPSE 1 0.0001
136 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
137 OSTEOMYELITIS 1 0.0001
138 RESPIRATORY FAILURE 4 0.0001
139 ACCIDENTAL OVERDOSE 2 0.0001
140 RESTLESSNESS 2 0.0001
141 HEPATIC FUNCTION ABNORMAL 2 0.0001
142 MIDDLE INSOMNIA 1 0.0001
143 BLOOD SODIUM DECREASED 1 0.0001
144 HYPOCALCAEMIA 1 0.0001
145 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
146 PRODUCT ADMINISTRATION ERROR 1 0.0000
147 FEEDING DISORDER 1 0.0000
148 NEUTROPHIL COUNT DECREASED 2 0.0000
149 PERITONITIS 1 0.0000
150 PULMONARY HYPERTENSION 1 0.0000
151 RHABDOMYOLYSIS 2 0.0000
152 POOR QUALITY SLEEP 1 0.0000
153 NO ADVERSE EVENT 8 0.0000
154 HYPOKALAEMIA 2 0.0000
155 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
156 PRODUCT PRESCRIBING ERROR 1 0.0000
157 ENCEPHALOPATHY 1 0.0000
158 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
159 PNEUMONIA ASPIRATION 1 0.0000
160 GASTRIC CANCER 1 0.0000
161 BRADYCARDIA 2 0.0000
162 CARDIAC FAILURE 3 0.0000
163 BLOOD BILIRUBIN INCREASED 1 0.0000
164 PALLOR 1 0.0000
165 CARDIAC ARREST 3 0.0000
166 RESPIRATORY ARREST 1 0.0000
167 DIVERTICULITIS 1 0.0000
168 FEELING COLD 1 0.0000
169 CONVULSION 2 0.0000
170 ANGINA PECTORIS 1 0.0000
171 RESPIRATORY DISORDER 1 0.0000
172 CORONARY ARTERY DISEASE 1 0.0000
173 PLEURAL EFFUSION 2 0.0000
174 SWOLLEN TONGUE 1 0.0000
175 METABOLIC ACIDOSIS 1 0.0000
176 LACTIC ACIDOSIS 1 0.0000
177 IMPAIRED HEALING 1 0.0000
178 FEBRILE NEUTROPENIA 2 0.0000
179 LIP SWELLING 1 0.0000
180 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
181 HYPOXIA 1 0.0000
182 PLATELET COUNT DECREASED 3 0.0000
183 CRYING 1 0.0000
184 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
185 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
186 PLASMA CELL MYELOMA 1 0.0000
187 TREMOR 4 0.0000
188 ROAD TRAFFIC ACCIDENT 1 0.0000
189 TACHYCARDIA 2 0.0000
190 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
191 ADVERSE EVENT 2 0.0000
192 BLOOD CHOLESTEROL INCREASED 1 0.0000
193 ARRHYTHMIA 1 0.0000
194 OCULAR HYPERAEMIA 1 0.0000
195 PULMONARY EMBOLISM 2 0.0000
196 MIGRAINE 2 0.0000
197 PRODUCTIVE COUGH 1 0.0000
198 BLOOD GLUCOSE DECREASED 1 0.0000
199 HYPOGLYCAEMIA 1 0.0000
200 LUNG DISORDER 1 0.0000
201 LEUKOPENIA 1 0.0000
202 SYNCOPE 2 0.0000
203 FLUSHING 2 0.0000
204 CHEST DISCOMFORT 2 0.0000
205 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
206 DRUG EFFECT DECREASED 1 0.0000
207 DISTURBANCE IN ATTENTION 1 0.0000
208 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
209 TREATMENT NONCOMPLIANCE 1 0.0000
210 SEPSIS 2 0.0000
211 OXYGEN SATURATION DECREASED 1 0.0000
212 LETHARGY 1 0.0000
213 CHILLS 2 0.0000
214 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
215 HYPERSENSITIVITY 3 0.0000
216 INJECTION SITE ERYTHEMA 2 0.0000
217 SWELLING FACE 1 0.0000
218 RENAL FAILURE 2 0.0000
219 BLOOD PRESSURE DECREASED 1 0.0000
220 DEHYDRATION 2 0.0000
221 NEOPLASM MALIGNANT 1 0.0000
222 HYPOTENSION 3 0.0000
223 PRODUCT QUALITY ISSUE 2 0.0000
224 INFECTION 2 0.0000
225 AGITATION 1 0.0000
226 ABDOMINAL PAIN 3 0.0000
227 CARDIAC FAILURE CONGESTIVE 1 0.0000
228 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
229 RENAL IMPAIRMENT 1 0.0000
230 MALAISE 5 0.0000
231 DEVICE ISSUE 1 0.0000
232 ADVERSE DRUG REACTION 1 0.0000
233 MUSCLE SPASMS 2 0.0000
234 CHEST PAIN 2 0.0000
235 CARDIAC DISORDER 1 0.0000
236 NEUROPATHY PERIPHERAL 1 0.0000
237 CONTUSION 1 0.0000
238 HEART RATE INCREASED 1 0.0000
239 DIZZINESS 5 0.0000
240 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
241 ERYTHEMA 2 0.0000
242 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
243 HAEMORRHAGE 1 0.0000
244 PNEUMONIA 3 0.0000
245 CONSTIPATION 2 0.0000
246 DYSPNOEA 5 0.0000
247 SEIZURE 1 0.0000
248 DISEASE PROGRESSION 1 0.0000
249 OEDEMA PERIPHERAL 1 0.0000
250 ANXIETY 2 0.0000
251 RASH 3 0.0000
252 BLOOD PRESSURE INCREASED 1 0.0000
253 HOSPITALISATION 1 0.0000
254 VOMITING 3 0.0000
255 CONFUSIONAL STATE 1 0.0000
256 PYREXIA 2 0.0000
257 NASOPHARYNGITIS 1 0.0000
258 BLOOD GLUCOSE INCREASED 1 0.0000
259 ANAEMIA 1 0.0000
260 PRURITUS 2 0.0000
261 ALOPECIA 1 0.0000
262 NAUSEA 4 0.0000
263 SOMNOLENCE 1 0.0000
264 ABDOMINAL PAIN UPPER 1 0.0000
265 HYPERTENSION 1 0.0000
266 WEIGHT INCREASED 1 0.0000
267 INCORRECT DOSE ADMINISTERED 1 0.0000
268 DECREASED APPETITE 1 0.0000
269 BACK PAIN 1 0.0000
270 FEELING ABNORMAL 1 0.0000
271 CONDITION AGGRAVATED 1 0.0000
272 INJECTION SITE PAIN 1 0.0000
273 DIARRHOEA 2 0.0000
274 ASTHENIA 1 0.0000
275 PAIN 1 0.0000
276 HEADACHE 1 0.0000
277 DRUG INEFFECTIVE 2 0.0000
278 FATIGUE 1 0.0000
279 DEATH 1 0.0000
280 OFF LABEL USE 1 0.0000